At any time, Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, is participating in dozens of clinical trials, representing a wide gamut of diagnoses and moving our understanding of childhood cancers forward. Norton Children’s Cancer Institute is a member of the Children’s Oncology Group and typically opens the same treatment studies and…
Acute lymphoblastic leukemia (ALL) is the most common cancer among children, and its symptoms can be vague. Some, but not all, children with ALL present with a mix of symptoms that can include fever, fatigue and bleeding. Studies also have shown that about a third of children with ALL may have musculoskeletal symptoms. About three-quarters…
Every day at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, pharmacists round with the teams. We’re part of the decision-making process for hematology, oncology and stem cell transplant patients. Our goal is to help give these children the best possible outcome and keep them safe. For many patients, this involves following…
Natalie F. Slone, D.O., a pediatric hematology/oncology specialist focusing on solid tumors and sarcomas in children and teens, has joined Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. Her interest and passion for treating these cancers are in the challenge and the need to sometimes get creative to find the right solution. “It’s…
Addressing the emotional effects of cancer and its treatment on children and young adults can improve outcomes and help manage adverse effects of treatment. Norton Children’s is presenting a three-part series drawing from a recent continuing medical education opportunity with specialists from Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. The presenters…
Jun Zhao, D.O., pediatric hematologist/oncologist, has been named physician lead for outpatient care at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. Dr. Zhao will work with Ashok B. Raj, M.D., medical director, Norton Children’s Cancer Institute, and division chief of pediatric hematology/oncology for the University of Louisville School of Medicine Department…
Addressing the emotional effects of cancer and its treatment on children and young adults can improve outcomes and help manage adverse effects of treatment. Norton Healthcare is presenting a three-part series drawing from a recent continuing medical education (CME) opportunity on evidence-based standards for care as applied to pediatric cancer patients and their families. The…
It used to be that pediatric cancer was almost always fatal. Fortunately, now almost 85% of kids survive to have a full and rewarding future. Those children and their families often need help adjusting emotionally during and after their ordeal. “With cancer and blood disorders, there can be a lot of additional stress, and even…
Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, now offers CAR-T immunotherapy treatment for children who have difficult-to-treat acute lymphoblastic leukemia (ALL). Norton Children’s Cancer Institute is the only pediatric cancer program in Kentucky approved as a provider site for CAR-T immunotherapy. CAR-T works by reprogramming the patient’s own T cells so…
In 2016, not long after his 4th birthday, Jameson Milby began experiencing headaches, nausea and vomiting. The Milby family’s pediatrician, James A. Tavelli, M.D., with Norton Children’s Medical Group – Okolona, ordered an MRI, which showed a large brain tumor in the posterior fossa. The following day, William C. Gump, M.D., pediatric neurosurgeon with Norton…
Sunnye Mayes, Ph.D. ABPP, has joined Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, as hematology/oncology psychologist. Dr. Mayes is the only provider in Kentucky or Southern Indiana certified by the American Board of Professional Psychology in clinical child and adolescent psychology. Refer a Patient Use Norton EpicLink to quickly and easily…
The American Society of Hematology (ASH) has new guidelines for immune thrombocytopenia, also called immune thrombocytopenic purpura (ITP), in children, including more outpatient management, more observation, and fewer medications. “The guidelines came about as the result of clinical evidence and experience,” said Ashok B. Raj, M.D., pediatric hematologist/oncologist with Norton Children’s Cancer Institute, affiliated with…